From the Journals

Reassurance for women taking certolizumab during pregnancy

Publish date: April 6, 2018

 

FROM ARTHRITIS & RHEUMATOLOGY


The study was funded by UCB Pharma. One author was a contractor for, and three were employees of, UCB Pharma. Six authors declared grants, consulting fees, and other remuneration from pharmaceutical companies, including UCB Pharma.

SOURCE: Clowse MEB et al. Arthritis & Rheumatology. 2018 Apr 5. doi: 10.1002/art.40508.

Pages

Recommended Reading

Interventions urged to stop rising NAS, stem Medicaid costs
MDedge Family Medicine
Maternal biologic therapy does not affect infant vaccine responses
MDedge Family Medicine
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Family Medicine
Axial SpA disease activity remains mostly stable throughout pregnancy
MDedge Family Medicine
Here’s one issue blue and red states agree on: Preventing deaths of expectant and new mothers
MDedge Family Medicine
MDedge Daily News: Why most heart failure may be preventable
MDedge Family Medicine
Higher preconception blood pressure linked to pregnancy loss
MDedge Family Medicine
Metformin reduces preterm births, late miscarriages in PCOS
MDedge Family Medicine
ACOG: Ob.gyns. can help protect pregnant women’s workplace rights
MDedge Family Medicine
Statins, ACE inhibitors linked to fetal cardiac anomalies
MDedge Family Medicine